Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
9.85M
-
Shares change
-
+986K
-
Total reported value, excl. options
-
$293M
-
Value change
-
+$29.9M
-
Put/Call ratio
-
3.91
-
Number of buys
-
58
-
Number of sells
-
-41
-
Price
-
$29.67
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q2 2022
124 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q2 2022.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.85M shares
of 22.3M outstanding shares and own 44.21% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.98M shares), VANGUARD GROUP INC (814K shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (557K shares), DIMENSIONAL FUND ADVISORS LP (539K shares), STATE STREET CORP (466K shares), EMERALD ADVISERS, LLC (456K shares), THOMPSON SIEGEL & WALMSLEY LLC (436K shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (368K shares), EMERALD MUTUAL FUND ADVISERS TRUST (357K shares), and Global Alpha Capital Management Ltd. (324K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.